CEL-SCI Future Growth
Future criteria checks 2/6
CEL-SCI is forecast to grow earnings and revenue by 19% and 95.4% per annum respectively while EPS is expected to grow by 29.7% per annum.
Key information
19.0%
Earnings growth rate
29.7%
EPS growth rate
Biotechs earnings growth | 21.1% |
Revenue growth rate | 95.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2026 | 8 | -17 | N/A | N/A | 1 |
9/30/2025 | 5 | -26 | -26 | -23 | 2 |
9/30/2024 | 0 | -37 | -39 | -36 | 2 |
12/31/2023 | N/A | -31 | -23 | -23 | N/A |
9/30/2023 | N/A | -32 | -23 | -23 | N/A |
6/30/2023 | N/A | -34 | -23 | -23 | N/A |
3/31/2023 | N/A | -35 | -23 | -23 | N/A |
12/31/2022 | N/A | -37 | -19 | -18 | N/A |
9/30/2022 | N/A | -38 | -19 | -18 | N/A |
6/30/2022 | N/A | -37 | -19 | -18 | N/A |
3/31/2022 | N/A | -36 | -21 | -18 | N/A |
12/31/2021 | N/A | -37 | -26 | -20 | N/A |
9/30/2021 | N/A | -37 | -28 | -19 | N/A |
6/30/2021 | 0 | -34 | -27 | -18 | N/A |
3/31/2021 | 0 | -35 | -25 | -16 | N/A |
12/31/2020 | 1 | -33 | -21 | -15 | N/A |
9/30/2020 | 1 | -30 | -18 | -15 | N/A |
6/30/2020 | 1 | -30 | -17 | -16 | N/A |
3/31/2020 | 1 | -32 | -17 | -17 | N/A |
12/31/2019 | 0 | -29 | -17 | -16 | N/A |
9/30/2019 | 0 | -22 | -17 | -16 | N/A |
6/30/2019 | 1 | -32 | -17 | -17 | N/A |
3/31/2019 | 1 | -26 | -15 | -15 | N/A |
12/31/2018 | 1 | -24 | -15 | -15 | N/A |
9/30/2018 | 0 | -32 | -13 | -13 | N/A |
6/30/2018 | 0 | -22 | -13 | -13 | N/A |
3/31/2018 | 0 | -20 | -13 | -13 | N/A |
12/31/2017 | 0 | -24 | -12 | -12 | N/A |
9/30/2017 | N/A | -14 | N/A | -14 | N/A |
6/30/2017 | 0 | -10 | N/A | -17 | N/A |
3/31/2017 | 0 | -10 | N/A | -20 | N/A |
12/31/2016 | 0 | -10 | N/A | -21 | N/A |
9/30/2016 | 0 | -12 | N/A | -23 | N/A |
6/30/2016 | 0 | -20 | N/A | -22 | N/A |
3/31/2016 | 0 | -21 | N/A | -22 | N/A |
12/31/2015 | 1 | -25 | N/A | -24 | N/A |
9/30/2015 | 1 | -35 | N/A | -24 | N/A |
6/30/2015 | 1 | -32 | N/A | -24 | N/A |
3/31/2015 | 0 | -30 | N/A | -24 | N/A |
12/31/2014 | 0 | -31 | N/A | -22 | N/A |
9/30/2014 | 0 | -28 | N/A | -23 | N/A |
6/30/2014 | 0 | -23 | N/A | -21 | N/A |
3/31/2014 | 0 | -25 | N/A | -18 | N/A |
12/31/2013 | 0 | -12 | N/A | -16 | N/A |
9/30/2013 | 0 | -9 | N/A | -14 | N/A |
6/30/2013 | 0 | -10 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CVM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CVM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CVM's revenue (95.4% per year) is forecast to grow faster than the US market (7.9% per year).
High Growth Revenue: CVM's revenue (95.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CVM's Return on Equity is forecast to be high in 3 years time